Kenvue Inc.
20.90
-0.13 (-0.62%)
At close: Jan 15, 2025, 10:31 AM

Company Description

Kenvue Inc. operates as a consumer health company worldwide.

The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health.

The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands.

The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names.

The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands.

The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

Kenvue Inc.
Kenvue Inc. logo
Country United States
IPO Date May 4, 2023
Industry Household & Personal Products
Sector Consumer Defensive
Employees 22,000
CEO Thibaut Mongon

Contact Details

Address:
199 Grandview Road
Skillman, New Jersey
United States
Website https://www.kenvue.com

Stock Details

Ticker Symbol KVUE
Exchange NYSE
Fiscal Year February - January
Reporting Currency USD
CIK Code 0001944048
CUSIP Number 49177J102
ISIN Number US49177J1025
Employer ID 88-1032011
SIC Code 2844

Key Executives

Name Position
Thibaut Mongon Chief Executive Officer & Director
Paul Ruh Chief Financial Officer
Bernardo Tavares Chief Data & Technology Officer
Carlton Lawson Group President of EMEA & Latin America
Dr. Caroline Tillett Ph.D. Chief Scientific Officer
Ellie Bing Xie Group President of Asia Pacific
Heather R. Howlett Chief Accounting Officer
Matthew Orlando General Counsel
Meredith Stevens Chief Operations Officer
Tina Romani Head of Investor Relations

Latest SEC Filings

Date Type Title
Dec 13, 2024 4 Filing
Dec 13, 2024 4 Filing
Dec 13, 2024 4 Filing
Dec 03, 2024 4 Filing
Dec 03, 2024 4 Filing
Dec 03, 2024 4 Filing
Dec 03, 2024 4 Filing
Dec 03, 2024 4 Filing
Dec 03, 2024 4 Filing
Dec 03, 2024 4 Filing